NEW YORK (GenomeWeb News) - GeneGo said last week that Almac Diagnostics, a division of Almac Group, has licensed its MetaCore data-mining platform.
Almac Diagnostics will use MetaCore to help develop its microarray-based products diagnosing and treating cancer.
The company will also use the platform in its genomic services division.
"We compared several platforms before we finally decided on GeneGo,” said Vitali Proutski, bioinformatics manager at Almac Diagnostics, in a statement.
Financial terms of the agreement were not provided.